Arishi Wjdan A, Alhadrami Hani A, Zourob Mohammed
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, P.O. Box 80402, Jeddah 21589, Saudi Arabia.
Molecular Diagnostic laboratory, King Abdulaziz University Hospital, King Abdulaziz University, P.O. BOX 80402, Jeddah 21589, Saudi Arabia.
Micromachines (Basel). 2021 May 5;12(5):519. doi: 10.3390/mi12050519.
Sickle cell disease (SCD) is a widespread disease caused by a mutation in the beta-globin gene that leads to the production of abnormal hemoglobin called hemoglobin S. The inheritance of the mutation could be homozygous or heterozygous combined with another hemoglobin mutation. SCD can be characterized by the presence of dense, sickled cells that causes hemolysis of blood cells, anemia, painful episodes, organ damage, and in some cases death. Early detection of SCD can help to reduce the mortality and manage the disease effectively. Therefore, different techniques have been developed to detect the sickle cell disease and the carrier states with high sensitivity and specificity. These techniques can be screening tests such as complete blood count, peripheral blood smears, and sickling test; confirmatory tests such as hemoglobin separation techniques; and genetic tests, which are more expensive and need to be done in centralized labs by highly skilled personnel. However, advanced portable point of care techniques have been developed to provide a low-cost, simple, and user-friendly device for detecting SCD, for instance coupling solubility tests with portable devices, using smartphone microscopic classifications, image processing techniques, rapid immunoassays, and sensor-based platforms. This review provides an overview of the current and emerging techniques for sickle cell disease detection and highlights the different potential methods that could be applied to help the early diagnosis of SCD.
镰状细胞病(SCD)是一种广泛存在的疾病,由β-珠蛋白基因突变引起,该突变导致产生异常血红蛋白,即血红蛋白S。该突变的遗传方式可为纯合子,也可为与另一种血红蛋白突变相结合的杂合子。SCD的特征表现为存在密集的镰状细胞,这些细胞会导致血细胞溶血、贫血、疼痛发作、器官损伤,在某些情况下还会导致死亡。早期检测SCD有助于降低死亡率并有效控制该疾病。因此,人们已开发出不同技术来高灵敏度和特异性地检测镰状细胞病及其携带者状态。这些技术包括筛查试验,如全血细胞计数、外周血涂片和镰变试验;确证试验,如血红蛋白分离技术;以及基因检测,基因检测成本更高,需要由高技能人员在集中实验室进行。然而,现已开发出先进的便携式即时检测技术,以提供一种低成本、简单且用户友好的设备来检测SCD,例如将溶解度试验与便携式设备相结合、使用智能手机显微镜分类、图像处理技术、快速免疫测定和基于传感器的平台。本综述概述了当前及新兴的镰状细胞病检测技术,并着重介绍了可用于帮助早期诊断SCD的不同潜在方法。